Highlights
- Revenue from operations increased 19% year-on-year during Q1 FY27.
- EBITDA grew 20% YoY, while EBITDA margin expanded by 20 basis points.
- Net profit rose 35% YoY, supported by higher operating performance.
- Total patient volumes increased across both inpatient and outpatient segments.
- The company continued executing its hospital expansion strategy during the quarter.
Revenue and profitability improve in the first quarter
Park Medi World Limited (NSE:PARKHOSPS) reported its unaudited financial results for the quarter ended 30 June 2026, recording year-on-year growth across its key financial metrics. The company reported higher revenue, EBITDA and net profit during the quarter while continuing to invest in expanding its hospital network across North India.
Revenue from operations stood at INR 4,757 million during Q1 FY27, compared with INR 3,988 million in the corresponding quarter of the previous year, representing a 19% year-on-year increase. Sequentially, revenue also improved from INR 4,604 million reported in Q4 FY26.
Operating earnings remain on an upward trajectory
The company's operating performance also improved during the reporting period. EBITDA, excluding other income, increased to INR 1,261 million from INR 1,049 million in Q1 FY26, reflecting a 20% year-on-year increase.
EBITDA margin stood at 26.5%, compared with 26.3% in the corresponding quarter last year, resulting in a 20 basis point expansion. Although the company added substantial new hospital capacity during the period, it maintained operating margins broadly in line with historical levels while continuing to integrate recently commissioned facilities.
Data Source: Company Filings; Analysis: Kalkine Group
Net profit outpaces revenue growth
Profitability improved further at the bottom line. Net profit for Q1 FY27 increased to INR 886 million, compared with INR 655 million in Q1 FY26, representing a 35% year-on-year increase.
Net profit margin expanded to 18.6% from 16.4% in the corresponding quarter last year, an improvement of 220 basis points. Earnings per share also increased to INR 2.05, compared with INR 1.70 reported during Q1 FY26.
The improvement in net profit exceeded revenue growth during the quarter, reflecting higher profitability while the company continued expanding its operating footprint.
Patient volumes continue to increase
Operational indicators also recorded year-on-year growth during the quarter. Total patient volumes increased to 249.8 thousand, compared with 213.9 thousand in Q1 FY26, representing a 17% increase.
Inpatient (IPD) volumes rose to 26.3 thousand patients from 22.8 thousand, while outpatient (OPD) volumes increased from 191.2 thousand to 223.4 thousand during the same period.
Total bed capacity reached 3,960 beds, compared with 3,000 beds a year earlier, reflecting the commissioning of new facilities and ongoing expansion initiatives. However, occupancy during the quarter stood at 55.6%, compared with 67.8% in Q1 FY26, as newly operational hospitals continued their initial ramp-up phase.
Expansion continues alongside earnings growth
During the quarter, the company commissioned its 350-bed Panchkula hospital, its largest greenfield hospital to date. It also entered into agreements to acquire hospitals in Rudrapur and Zirakpur, while approving the expansion of its Palam Vihar hospital in Gurugram through the addition of 100 beds.
Management stated that these projects form part of its plan to commission 1,490 beds during calendar year 2026, representing approximately 46% growth over the closing bed capacity of 3,250 beds in 2025.
The company noted that newly commissioned facilities are still progressing through their utilisation phase, with management focusing on integration and improving occupancy across these hospitals.
Management highlights operational priorities
According to the management commentary accompanying the results, the company intends to focus on integrating recently acquired hospitals, improving utilisation at newly commissioned facilities and maintaining profitability while continuing its expansion programme.
The company also reported term bank debt of INR 256 million as of 30 June 2026 and fixed deposits of INR 2,998 million, providing financial flexibility as expansion projects continue.
Conclusion
Park Medi World began FY27 with higher revenue, operating earnings and net profit while simultaneously executing one of the largest hospital expansion programmes in its history. The company reported double-digit growth across its key financial metrics, supported by increasing patient volumes and a growing hospital network. As recently commissioned hospitals continue to mature and additional facilities become operational during the year, future quarters are expected to provide further visibility into utilisation trends and the contribution of the expanded capacity.
FAQs
Q: How much revenue did Park Medi World report in Q1 FY27?
A: The company reported INR 4,757 million in revenue from operations during Q1 FY27, representing 19% year-on-year growth.
Q: What was the EBITDA reported for Q1 FY27?
A: EBITDA (excluding other income) stood at INR 1,261 million, up 20% from INR 1,049 million in Q1 FY26.
Q: How much did net profit increase during the quarter?
A: Net profit increased 35% year-on-year to INR 886 million.
Q: What was the EBITDA margin during Q1 FY27?
A: EBITDA margin was 26.5%, compared with 26.3% in the corresponding quarter of the previous year.
Q: Why did occupancy decline despite higher patient volumes?
A: According to the company, newly commissioned hospitals are still ramping up operations, which affected occupancy even as patient volumes and bed capacity increased.